Embol-X, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2034
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 16, 2027The maintenance fee for High Torque Catheter and Methods of Manufacture (US 10,350,382) comes due Jan 16, 2027. Unpaid by Jul 16, 2027, it lapses early.
- 1 fee due May 3, 2027The maintenance fee for Device and methods for transvascular tumor embolization with integrated flow regulation (US 9,174,020) comes due May 3, 2027. Unpaid by Nov 3, 2027, it lapses early.
- 1 fee due Jun 8, 2027The maintenance fee for Device and Methods for Transvascular Tumor Embolization with Integrated Flow Regulation (US 9,205,226) comes due Jun 8, 2027. Unpaid by Dec 8, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,205,226 | Device and Methods for Transvascular Tumor Embolization with Integrated Flow Regulation In force · High confidence | In force | High confidence | |
| US 9,844,383 | Devices and Methods for Low Pressure Tumor Embolization In force · High confidence | In force | High confidence | |
| US 10,130,762 | Device and Methods for Transvascular Tumor Embolization with Integrated Flow Regulation In force · High confidence | In force | High confidence | |
| US 10,667,822 | Devices and Methods for Low Pressure Tumor Embolization In force · High confidence | In force | High confidence | |
| US 9,174,020 | Device and methods for transvascular tumor embolization with integrated flow regulation In force · From the USPTO record | In force | From the USPTO record | |
| US 11,123,482 | Device and methods for transvascular tumor embolization In force · From the USPTO record | In force | From the USPTO record | |
| US 9,550,046 | Balloon Catheter and Methods of Fabrication and Use In force · High confidence | In force | High confidence | |
| US 10,780,252 | Catheter with inflatable balloon In force · From the USPTO record | In force | From the USPTO record | |
| US 10,786,660 | Occlusion Balloon Catheter and Methods of Fabrication and Use In force · High confidence | In force | High confidence | |
| US 11,464,948 | Balloon Catheters and Methods of Manufacture and Use In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 15: 9 lapsed for an unpaid fee · 111 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
7 abandoned · 2 no status recorded